1. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core–Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy
   Bing-Chen Zhang et al, 2020, ACS Applied Materials & Interfaces CrossRef
2. Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective
   Eleonora Russo et al, 2021, International Journal of Molecular Sciences CrossRef
3. Formulation of polymeric nanoparticles loaded sorafenib; evaluation of cytotoxicity, molecular evaluation, and gene expression studies in lung and breast cancer cell lines
   Ahmed A. H. Abdellatif et al, 2022, Nanotechnology Reviews CrossRef
4. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles
   Rosa Maria Iacobazzi et al, 2022, Journal of Colloid and Interface Science CrossRef
5. Preparation and characterization of Sorafenib nano-emulsion: impact on pharmacokinetics and toxicity; an in vitro and in vivo study
   Dalia Zaafar et al, 2024, Drug Delivery and Translational Research CrossRef
6. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma
   Sarah J. M. Hale et al, 2019, Bioconjugate Chemistry CrossRef